Concepedia

Bertrand Allard

BA

Statistics

Publications

25

Citations

2.3K

H-Index

18

Active since

2009

Affiliations

Centre Hospitalier de l’Université de Montréal(Current)

Université de Montréal

Université Paris Cité

Commissariat à l'Énergie Atomique et aux Énergies Alternatives

Institut de Biologie et Technologies

Bertrand Allard is an author at Centre Hospitalier de l’Université de Montréal specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2009–2023

25

Publications

25

Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs

Bertrand Allard, Sandra Pommey, Mark J. Smyth et al. · Clinical Cancer Research · 2013 · 442 citations

Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses

Paul A. Beavis, Nicole Milenkovski, Melissa A. Henderson et al. · Cancer Immunology Research · 2015 · 314 citations

, , +18

Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor

Deepak Mittal, Arabella Young, Kimberley Stannard et al. · Cancer Research · 2014 · 238 citations

, , +19

Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial

Laurence Buisseret, Sandra Pommey, Bertrand Allard et al. · Annals of Oncology · 2017 · 231 citations · Full text

CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer

Bruno G. Leclerc, Roxanne Charlebois, Guillaume Chouinard et al. · Clinical Cancer Research · 2015 · 193 citations

1–5 of 25